Karsten Voermann - 12 Mar 2024 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Role
Chief Financial Officer
Signature
/s/ Gracye Cheng, Attorney-in-Fact for Karsten Voermann
Issuer symbol
GDRX
Transactions as of
12 Mar 2024
Transactions value $
$0
Form type
4
Filing time
14 Mar 2024, 17:12:17 UTC
Previous filing
08 Mar 2024
Next filing
10 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GDRX Class A Common Stock 212K 12 Mar 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GDRX Restricted Stock Unit Award $0 +357K $0.00 357K 12 Mar 2024 Class A Common Stock 357K Direct F1, F2
transaction GDRX Stock Option (Right to Buy) Award $0 +516K $0.00 516K 12 Mar 2024 Class A Common Stock 516K $7.22 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.
F3 The option will vest and become exercisable as to 25% of the underlying shares on January 8, 2025 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.